Clinical aspects of side effects on intermittent rifampicin regimen.
D058186:Acute Kidney Injury / Q000139:chemically induced; D000906:Antibodies; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005334:Fever / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008111:Liver Function Tests; D009325:Nausea / Q000139:chemically induced; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology
D000906:Antibodies; D004977:Ethambutol; D012293:Rifampin